GE HealthCare Technologies Inc (GEHC-Q)

He doesn't know it that well and already has exposure to the medical devices sector. He holds Medtronic, Boston Scientific, Intuitive Surgical which are all performing well. He feels that GEHC has relatively low growth.

Lots of competition. Controlled by government spending and healthcare. Not as excited about this as about GEV, but the PE is a lot lower so you could get some upside there. He'd rather hold GEV.

Trades at 21x PE. It's hated by analysts, but he likes it. Wait for another downgrade before entering.

Are his favourite healthcare-AI play.

They've been hurt by China, but had a decent quarter. He bought the weakest of the three GE companies. He will ultimately make money on this.

GE did a great job managing their Aerospace division, including its debt, then spinning it off. He owns no GE division, but like the healthcare division the most. Is a little concerned with their debt, but trades at 18x with solid cash flow and has solid prospects.

He likes all three GE companies, but this is his favourite, because he likes their strategy of using AI in their MRIs.

One of the GE spinoffs. Larry Culp did a fantastic job turning GE around. Priced aggressively. Attractive at 10-15% below where it is now.

He owns a big position. Likes this a lot and it's doing many great things. It's so cheap. Is sticking with this long-term. Likes their business which is MRIs.

Spinoff from GE parent. Not buying shares at this time. Waiting to see how management performs. Strong sector (healthcare), but performance remains to be seen. 

Spun out from GE. He's been buying it this year and holds a large position. They reported a great beat in late July. Eventually, GEHC will decouple from the rest of healthcare which has been lagging. (Maybe Wall St is nervous about Washington taking shots at healthcare in the election year coming up.) Shares are down 12% this month, and this is a cheap, great opportunity.

This GE health spin-off's equipment will be in big demand next year when doctors conduct MRIs to measure plaque in the brain (to determine which patients get the new Alzheimer's drug). Huge demand. Why are shares down 12 points since their report. Makes no sense. He bought more shares to average down.

Getting good reviews. He's done some research into it. It's screening quite well, there's some opportunity here. A good healthcare offering.

He's been buying it. You will need an MRI before you can get into an Alzheimer's program. GEHC will have to talk about AI in their business when they report next week.

He bought it last week. Has more room to run. Spunoff by GE to start the year. Is up 35% YTD. Their scanners catch Alzheimer's. He's bullish on medical devices. Trades at 18x 2024 PE. Is in a slight pullback now.